CUFinder

Alex Tsodikov

Alex Tsodikov

University of Michigan-Dearborn

H-index: 41

North America-United States

Contact Alex Tsodikov

About Alex Tsodikov

Alex Tsodikov, With an exceptional h-index of 41 and a recent h-index of 20 (since 2020), a distinguished researcher at University of Michigan-Dearborn, specializes in the field of Stochastic Models, Survival Analysis, Cancer, Self-consistency, Screening.

His recent articles reflect a diverse array of research interests and contributions to the field:

Efficiency of the Breslow estimator in semiparametric transformation models

National Long-term Survival Estimates After Radical Prostatectomy for Prostate Cancer

National population-based survival estimates after definitive radiation therapy for prostate cancer.

Package ‘nltm’

Outcomes after definitive radiation therapy for localized prostate cancer in a national health care delivery system

An interventional response phenotyping study in chronic low back pain: protocol for a mechanistic randomized controlled trial

Replicating the timing of androgen deprivation therapy randomized trial (TROG 03.06 and VCOG PR 01-03 [TOAD]) for recurrent prostate cancer using real-world observational data.

MP77-16 MANAGEMENT OF BIOCHEMICAL RECURRENCE AND INCIDENT METASTATIC DISEASE AFTER RADICAL PROSTATECTOMY FOR PROSTATE CANCER

Alex Tsodikov Information

University

Position

Department of Biostatistics

Citations(all)

6121

Citations(since 2020)

1685

Cited By

5022

hIndex(all)

41

hIndex(since 2020)

20

i10Index(all)

70

i10Index(since 2020)

39

Email

University Profile Page

Google Scholar

Alex Tsodikov Skills & Research Interests

Stochastic Models

Survival Analysis

Cancer

Self-consistency

Screening

Top articles of Alex Tsodikov

Efficiency of the Breslow estimator in semiparametric transformation models

Lifetime Data Analysis

2023/11/26

National Long-term Survival Estimates After Radical Prostatectomy for Prostate Cancer

Urology

2024/2/1

Alexander Zaslavsky
Alexander Zaslavsky

H-Index: 20

National population-based survival estimates after definitive radiation therapy for prostate cancer.

2023/2/20

David Elliott
David Elliott

H-Index: 31

Alexander Zaslavsky
Alexander Zaslavsky

H-Index: 20

Package ‘nltm’

2023/11/3

Outcomes after definitive radiation therapy for localized prostate cancer in a national health care delivery system

Cancer

2023/10/15

Alexander Zaslavsky
Alexander Zaslavsky

H-Index: 20

An interventional response phenotyping study in chronic low back pain: protocol for a mechanistic randomized controlled trial

Pain Medicine

2023/8/1

Andrew Schrepf
Andrew Schrepf

H-Index: 19

Susan L Murphy
Susan L Murphy

H-Index: 27

Laura Fisher
Laura Fisher

H-Index: 3

Ishtiaq Mawla
Ishtiaq Mawla

H-Index: 13

Eric Ichesco
Eric Ichesco

H-Index: 21

Courtney Cole
Courtney Cole

H-Index: 0

Replicating the timing of androgen deprivation therapy randomized trial (TROG 03.06 and VCOG PR 01-03 [TOAD]) for recurrent prostate cancer using real-world observational data.

2023/6/1

David Elliott
David Elliott

H-Index: 31

Alexander Zaslavsky
Alexander Zaslavsky

H-Index: 20

MP77-16 MANAGEMENT OF BIOCHEMICAL RECURRENCE AND INCIDENT METASTATIC DISEASE AFTER RADICAL PROSTATECTOMY FOR PROSTATE CANCER

The Journal of Urology

2023/4

David Elliott
David Elliott

H-Index: 31

Alexander Zaslavsky
Alexander Zaslavsky

H-Index: 20

The genetic heterogeneity and drug resistance mechanisms of relapsed refractory multiple myeloma

Nature communications

2022/6/29

Yi-Mi Wu
Yi-Mi Wu

H-Index: 34

Lisha Wang
Lisha Wang

H-Index: 22

Yu Ning
Yu Ning

H-Index: 2

Jin Zhou
Jin Zhou

H-Index: 17

Wallace Kb Chan
Wallace Kb Chan

H-Index: 9

Arvind Rao
Arvind Rao

H-Index: 49

Recurrence, metastasis, and survival after radical prostatectomy in the era of advanced treatments.

2022/6/1

Alexander Zaslavsky
Alexander Zaslavsky

H-Index: 20

Better Understanding the Timing Of Androgen Deprivation Trial Outcomes: Impacts of Prior Androgen Deprivation Therapy

JNCI Cancer Spectrum

2022/6/1

Theresa Devasia
Theresa Devasia

H-Index: 5

Alexander Zaslavsky
Alexander Zaslavsky

H-Index: 20

MP15-09 SURVIVAL ESTIMATES OF MEN WITH BIOCHEMICALLY RECURRENT PROSTATE CANCER AFTER RADICAL PROSTATECTOMY IN A NATIONAL COHORT

The Journal of Urology

2022/5

Alexander Zaslavsky
Alexander Zaslavsky

H-Index: 20

A copula‐based approach for dynamic prediction of survival with a binary time‐dependent covariate

Statistics in Medicine

2021/10/15

PD05-10 TOAD: WARTS AND ALL? SUBGROUP ANALYSES REVEALING DIFFERENTIAL TREATMENT EFFECTS IN THE TIMING OF ANDROGEN DEPRIVATION TRIAL

Journal of Urology

2021/9/1

Theresa Devasia
Theresa Devasia

H-Index: 5

Alexander Zaslavsky
Alexander Zaslavsky

H-Index: 20

The effects of intraoperative caffeine on postoperative opioid consumption and related outcomes after laparoscopic surgery: a randomized controlled trial

Anesthesia & Analgesia

2021/7/1

Duan Li
Duan Li

H-Index: 29

Giancarlo Vanini
Giancarlo Vanini

H-Index: 14

A Gaussian copula approach for dynamic prediction of survival with a longitudinal biomarker

Biostatistics

2021/7/1

Molecular profiling of ETS and non‐ETS aberrations in prostate cancer patients from northern India

The Prostate

2021/5/5

Bushra Ateeq
Bushra Ateeq

H-Index: 25

Corrigendum to: Molecular profiling of ETS and non-ETS aberrations in prostate cancer patients from northern India (The Prostate,(2015), 75, 10,(1051–1062), 10.1002/pros. 22989)

Prostate

2021/5/1

Heritability of the fibromyalgia phenotype varies by age

Arthritis & Rheumatology

2020/5

Diptavo Dutta
Diptavo Dutta

H-Index: 3

Seunggeun Lee
Seunggeun Lee

H-Index: 8

Laura J Scott
Laura J Scott

H-Index: 57

10A GLOBAL RESEARCH HIGHLIGHTS

Annals of Emergency Medicine

2020/4

See List of Professors in Alex Tsodikov University(University of Michigan-Dearborn)